FDA Approved: VEVYE — Supplemental Application (Harrow Eye, LLC)

View source ↗

Summary

The FDA approved a supplemental NDA for VEVYE (cyclosporine ophthalmic solution) submitted by Harrow Eye, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)

Snippet

SUPPL AP for VEVYE (CYCLOSPORINE OPHTHALMIC SOLUTION)